Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
The Journal of Organic Chemistry|October 28, 2010
Practical and scalable synthesis of a selective CCK1 receptor antagonistChristopher M Mapes, Neelakandha S Mani, Xiaohu Deng, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitorsCheryl A Grice, Kevin Tays, Haripada Khatuya, et al.Cell Reports|May 13, 2014
MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphatesYves Dondelinger, Wim Declercq, Sylvie Montessuit, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 8, 2009
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessmentAlan R Olzinski, Gregory H Turner, Roberta E Bernard, et al.Bioorganic & Medicinal Chemistry Letters|August 5, 2008
Aminomethylpiperazines as selective urotensin antagonistsMark A Hilfiker, Daohua Zhang, Sarah E Dowdell, et al.Plos One|May 9, 2014
Identification of selective small molecule inhibitors of the nucleotide-binding oligomerization domain 1 (NOD1) signaling pathwayDavid J Rickard, Clark A Sehon, Viera Kasparcova, et al.Plos One|August 13, 2013
Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathwayDavid J Rickard, Clark A Sehon, Viera Kasparcova, et al.British Journal of Pharmacology|August 20, 2010
GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivoD J Behm, N V Aiyar, A R Olzinski, et al.Journal of Medicinal Chemistry|October 10, 2008
Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseasesClark A Sehon, Gren Z Wang, Andrew Q Viet, et al.Bioorganic & Medicinal Chemistry Letters|November 4, 2011
CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole bloodGren Z Wang, Pamela A Haile, Tom Daniel, et al.Pageof 4